[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336620-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336620-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","deciphering-the-role-of-brafv600e-immunohistochemistry-in-breast-lesions-a-comprehensive-review","Deciphering the Role of BRAFV600E Immunohistochemistry in Breast Lesions - A Comprehensive Review","","The BRAFV600E mutation has been extensively studied in multiple cancers, yet its contribution to breast lesions remains less clearly defined. Immunohistochemistry (IHC) enables detection of BRAFV600E expression in breast tissue, supporting both diagnostic classification and prognostic evaluation. This comprehensive review synthesizes evidence on BRAFV600E IHC frequency, links to clinicopathological characteristics, and associated clinical implications. Findings are organized to support diagnosis, prognosis prediction, and treatment response assessment, while emphasizing the need to integrate IHC into diagnostic algorithms.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deciphering-the-role-of-brafv600e-immunohistochemistry-in-breast-lesions-a-comprehensive-review/336620/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deciphering-the-role-of-brafv600e-immunohistochemistry-in-breast-lesions-a-comprehensive-review/336620.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does BRAFV600E IHC support diagnosis of breast lesions?","Question",{"text":63,"@type":64},"BRAFV600E immunohistochemistry uses specific antibodies to detect and visualize BRAFV600E expression in tissue samples, helping classify breast lesion subtypes and inform diagnostic decisions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the stated clinical value of BRAFV600E IHC in prognosis?",{"text":68,"@type":64},"The review describes BRAFV600E IHC as useful for prognosis prediction by linking BRAFV600E expression with clinicopathological features and supporting risk-related interpretations.",{"name":70,"@type":61,"acceptedAnswer":71},"What research needs does the review highlight for the future?",{"text":72,"@type":64},"It recommends larger-scale studies to validate current findings, optimize detection techniques, and explore therapeutic interventions targeting BRAFV600E in breast cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336620,1791470929,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Received 06/21/2024  \nReview began 06/28/2024  \nReview ended 07/12/2024  \nPublished 07/18/2024  \n© Copyright 2024  \nKhan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.64872  \nOpen Access Review Article  \nPublished via DMIHER School of Epidemiology and Public Health  \nDeciphering the Role of BRAFV600E Immunohistochemistry in Breast Lesions: A Comprehensive Review  \nSimran Khan 1, Arvind Bhake 1, Shakti Sagar 1  \n1. Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND  \nCorresponding author: Simran Khan, [sabhatsimrankhan416@gmail.com](sabhatsimrankhan416@gmail.com)  \nAbstract  \nThe BRAFV600E mutation has been extensively studied in various cancers, but its role in breast lesions remains less understood. Immunohistochemistry (IHC) has emerged as a valuable tool for detecting BRAFV600E expression in breast tissue, aiding in diagnosis and prognosis. This comprehensive review examines the significance of BRAFV600E IHC in breast lesions, encompassing its frequency, association with clinicopathological features, and potential clinical implications. We summarize key findings, emphasizing their utility in diagnosis, prognosis prediction, and treatment response assessment. Additionally, we discuss implications for clinical practice, highlighting the need for integrating BRAFV600EIHC into diagnostic algorithms. Recommendations for future research include larger-scale studies to validate findings, optimize detection techniques, and explore therapeutic interventions targeting BRAFV600E in breast cancer. This review contributes to understanding the molecular landscape of breast lesions and informs clinical decision-making in their management.  \nCategories: Pathology  \nKeywords: clinical implications, prognosis, diagnosis, breast lesions, immunohistochemistry, brafv600e mutation  \nIntroduction And Background  \nThe BRAFV600E mutation is a well-studied genetic alteration commonly found in various cancers, including melanoma, colorectal, and thyroid [1] . This mutation involves a substitution of valine (V) for glutamic acid (E) at codon 600 of the BRAF gene, resulting in constitutive activation of the BRAF protein kinase. As a result, downstream signaling pathways such as the MAPK/ERK pathway become dysregulated, leading to uncontrolled cell proliferation, survival, and tumorigenesis [2] . Immunohistochemistry (IHC) is crucial in diagnosing and classifying breast lesions [3] . By utilizing specific antibodies to detect and visualize proteins of interest within tissue samples, IHC provides valuable information regarding the molecular characteristics of breast lesions. This technique aids pathologists in distinguishing between different subtypes of breast cancer, determining prognosis, and guiding treatment decisions [3] .  \nThis review aims to comprehensively explore the role of BRAFV600E IHC in the context of breast lesions. By synthesizing existing literature and research findings, this review aims to elucidate the significance of BRAFV600E expression as detected by IHC in various breast lesions, including ductal carcinoma in situ and invasive ductal carcinoma. Additionally, the review will examine the potential clinical implications of BRAFV600E IHC, its utility in prognosis prediction, treatment response prediction, and its role as a diagnostic biomarker. By providing a comprehensive overview of this topic, this review seeks to contribute to the current understanding of breast cancer biology and enhance clinical decision-making in managing breast lesions.  \nReview  \nBRAFV600E mutation in breast lesions  \nBackground on the BRAF Gene and Its Mutations  \nThe BRAF gene is a pivotal genetic component that encodes the B-Raf protein, a serine/threonine-protein","cbCaivoN3Q4msU8S","https://ap.wps.com/l/cbCaivoN3Q4msU8S","pdf",222312,"English","# Introduction And Background\n# Review\n## BRAFV600E mutation in breast lesions\n## Background on the BRAF Gene and Its Mutations\n## Frequency and Significance of the BRAFV600E Mutation in Breast Lesions","[{\"question\":\"How does BRAFV600E IHC support diagnosis of breast lesions?\",\"answer\":\"BRAFV600E immunohistochemistry uses specific antibodies to detect and visualize BRAFV600E expression in tissue samples, helping classify breast lesion subtypes and inform diagnostic decisions.\"},{\"question\":\"What is the stated clinical value of BRAFV600E IHC in prognosis?\",\"answer\":\"The review describes BRAFV600E IHC as useful for prognosis prediction by linking BRAFV600E expression with clinicopathological features and supporting risk-related interpretations.\"},{\"question\":\"What research needs does the review highlight for the future?\",\"answer\":\"It recommends larger-scale studies to validate current findings, optimize detection techniques, and explore therapeutic interventions targeting BRAFV600E in breast cancer.\"}]","Deciphering the Role of BRAFV600E Immunohistochemistry in Breast Lesions - A Comprehensive Review | PDF",1790015892,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a3bc14c4f0ac5c12bbf89e3ceedb496.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27b730f9330895fa2a2d49486c89fef8.webp",982,1389,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9ad33a2c93eb48c144b45dd250cfbc5.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/616d1c08ebac049cfcbfbd1bd3b98962.webp",980,1386]